Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid

References

• ANDERSON, R. J. and WEINSHILBOUM, R. M., 1980, Phenolsulphotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clinica et Chimica Acta, 103, 79–90. ANON., 1998, Clinical Pharmacokinetics: Drug Data Handbook (Auckland: ADIS Press).
   Google Scholar
• BENET, L., SVEIN, O. and SCHWARTZ, J., 1996, Design and optimization of dosage regimens; pharmacokinetic data. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon and A. G. Gilman (eds), The Pharmacological Basis of Therapeutics, 9th edn (New York: McGraw-Hill), pp. 1707–1793.
   Google Scholar
• BRITTAIN, R. T., FARMER, J. B. and MARSHALL, R. J., 1973, Some observations on the 02-adrenoceptor agonist properties of the isomers of salbutamol. British Journal of Clinical Pharmacology, 48, 144–147.
   Web of Science ®Google Scholar
• CAMPBELL, N. R. C., VAN LOON, J. A. and WEINSHILBOUM, R. M., 1987, Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isoenzymes of the thermostable form. Biochemical Pharmacology, 36, 1435–1446.
   Google Scholar
• CAPPIELLO, M., FRANCHI, M., RE, A. and PACICI, G. M., 1990b, Sulphotransferase and its substrate: adenosine-3-phosphate-5/-phosphosulphate in human foetal liver and placenta. Developmental Pharmacology and Therapeutics, 14, 62–65.
   PubMedGoogle Scholar
• CAPPIELLO, M., GI-m.1Am, L. and PACICI, G. M., 1990a, Differential distribution of phenol and catechol sulphotransferase in human liver and intestinal mucosa. Pharmacology, 40, 69–76.
   Google Scholar
• CAPPIELLO, M., GruHANI, L., RANE, A. and PACICI, G. M., 1991, Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus. Developmental Pharmacology and Therapeutics, 16, 83–88.
   PubMedGoogle Scholar
• FALANY, C. N. and KERL, E. A., 1990, Sulfation of minoxidil by human liver phenol sulfotransferase. Biochemical Pharmacology, 40, 1027–1032.
   PubMed Web of Science ®Google Scholar
• FOLDES, A. and MEEK, J., 1973, Rat brain phenolsulphotransferase-partial purification and some properties. Biochimica et Biophysica Acta, 327, 365–374.
   PubMed Web of Science ®Google Scholar
• HARTLEY, D. and MIDDLEMISS, D., 1971, Absolute configuration of the optical isomers of salbutamol. Journal of Medicinal Chemistry, 14, 895–896.
   Web of Science ®Google Scholar
• HUTCHINGS, M. J., PAULL, J. D., WILSON-EVERED, E. and MORGAN, D. J., 1987, Pharmacokinetics and metabolism of salbutamol in premature labour. British Journal of Clinical Pharmacology, 24, 69–75.
   Google Scholar
• KUDLACEK, P. E., CLEMENS, D. L., HALGARD, C. M. and ANDERSON, R. J., 1997, Characterization of recombinant human liver dehydroepiandrosterone sulfotransferase with minoxidil as the substrate. Biochemical Pharmacology, 53, 215–221.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. and RANDALL, R. J., 1951, Protein measurement with Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MCCALL, J. M., AIKEN, J. W., CHIDESTER, C. G., DUCHARME, D. W. and WENDLING, M. G., 1983, Pyrimidine and triazine 3-oxide sulfates: a new family of vasodilators. Journal of Medicinal Chemistry, 26, 1791–1793.
   PubMed Web of Science ®Google Scholar
• MORGAN, D. J., PAULL, J. D., RICHMOND, B. H., WIISON-EVERED, E. and ZICCONE, S. P., 1986, Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. British Journal of Clinical Pharmacology, 22, 587–593.
   Google Scholar
• NEUVONEN, P. J. and KIVISTO, K. T., 1988, Effect of magnesium hydroxyde on the absorption of tolfenamic and mefenamic acids. European Journal of Clinical Pharmacology, 35, 495–501.
   PubMed Web of Science ®Google Scholar
• PACICI, G. M. and DE SANTI, C., 1995, Human sulphotransferase. Classification and metabolic profile of the major isoforms. The point of view of the clinical pharmacologist. In G. M. Pacifici and G. N. Fracchia (eds), Advanced in Drug Metabolism in Man (Luxembourg: European Commission), pp. 311–349.
   Google Scholar
• PACICI, G. M., DE sANTI, c., muss', A. and AGELETTI, C. A., 1996, Interindividual variability in the rate of salbutamol sulphation in the human lung. European Journal of Clinical Pharmacology, 49, 299–303.
   Google Scholar
• PACICI, G. M., FRANCHI, M., GI-m.1Am, L. and RANE, A., 1990, Development of the glucuronyltransferaw and sulphotransferase towards 2-naphtol in human fetus. Developmental Pharmacology and Therapeutics, 14, 108–114.
   Google Scholar
• PACICI, G. M., GIUMANETTI, B., QuiLim, M. C., SPISNI, R., NERVI, M., GrumANI, L. and GOMENI, R, 1997, (—)-Salbutamol sulphation in the human liver and duodenal mucosa: interindividual variability. Xenobiotica, 27, 279–286.
   PubMed Web of Science ®Google Scholar
• PACICI, G. M. and NOTTOLI, R., 1995, Placental transfer of drugs administered to the mother. Clinical Pharmacokinetic Concepts, 28, 235–269.
   PubMed Web of Science ®Google Scholar
• PESOLA, G. R. and WALLE, T., 1992, Enantiomeric interaction in the sulfate conjugation of the [32-Pharmacology, 75, 125–128.
   Google Scholar
• RAFTOGIANIS, R. B., HER, C. and WEINSHILBOUM, R. M., 1996, Human phenol sulfotransferaw 473–487.
   Google Scholar
• REYNOLDS, E. F., 1996, Martindale: The Extra Pharmacopoeia, 31st edn (London: Royal Pharmaceutical Society).
   Google Scholar
• SINGER, S. S., 1994, The same enzymes catalyze sulfation of minoxidil, minoxidil analogous and catecholamines. Chemico-Biological Interactions, 92, 33–45. agonist drug albuterol by the human liver. Research Communication in Chemical Pathology interaction in the sulfate conjugation of the [32-Research Communication in Chemical Pathology pharmacogenetics: STP1* gene cloning and structural characterization. Pharmacogenetics, 6, R. M., 1996, Human phenol sulfotransferaw structural characterization. Pharmacogenetics, 6,
   Google Scholar
• SUNDARAM, R. S. and WEINSHILBOUM, R. M., 1989, Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Drug Metabolism and Disposition, 17, 255-264. Tam, A., Rizzo, G., CARRAL M. and PACICI, G. M., 1992, The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. British Journal of Clinical Pharmacology, 33, 299–304.
   Google Scholar
• VIETRI, M., DE SANT', C., PIETRABISSA, A., MOSCA, F. and PACICI, G. M., 2000a, Fenamate and the potent inhibition of human liver phenol sulphotransferase. Xenobiotica, 30, 111–116.
   Google Scholar
• VIETRI, M., DE SANTI, C., PIETRABISSA, A., MOSCA, F. and PACICI, G. M., 2000b, Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs. European Journal of Clinical Pharmacology, 56, 81–87.
   PubMed Web of Science ®Google Scholar
• WALLE, U. K., PESOLA, G. R. and WALLE, T., 1993, Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. British Journal of Clinical Pharmacology, 35, 413–418.
   PubMed Web of Science ®Google Scholar
• WEINSHELBOUM, R. M., 1986, Phenol sulphotransferase in humans: properties, regulation, and function. Federation Proceedings, 45, 2223–2228.
   PubMedGoogle Scholar
• WILBORN, T. W., COMER, K. A., DOOLEY, T. P., REARDON, I. M., HEINRIKSON, R. L. and FALANY, C. N., 1993, Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Molecular Pharmacology, 43, 70–77.
   PubMed Web of Science ®Google Scholar